Osteoarthritis

Journal of Association of Physicians of India

Volumn 53, Issue JUL, 2005, Pages 634-641

  Mahajan, A ^a   Verma, S ^a   Tandon, V ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

AGE; ARTICULAR CARTILAGE; BONE REMODELING; DISEASE COURSE; HUMAN; OSTEOARTHRITIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SEX DIFFERENCE;

ACETAMINOPHEN; AGE FACTORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BONE REMODELING; CARTILAGE, ARTICULAR; DISEASE PROGRESSION; HUMANS; OSTEOARTHRITIS; SEX FACTORS;

EID: 24644449672     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. th edition, Elsevier Saunders. 2005 .pp.1493-1513.
2. Chopra A, Patil J, Bilampelly V. The Bhigwan (India) COPCORD: Methodology and first information report, APLAR. J Rheumatol 1997;1:145-54.
3. Chopra A, Patil J, Bilampelly V, Relwane J, Tandle HS. Prevalence of rheumatic disease in rural population in Western India: A WHO-ILAR-COPCORD study. J Assoc Physicians India 2001;49:240-46.
4. Mahajan A, Jasrotia DS, Manhas AS, Jamwal SS. Prevalence of major rheumatic disorders in Jammu. JK Science 2003;5:63-66.
5. Martin JA, Buckwalter JA. Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerontology 2002;3:257-64.
6. Hunsche E, Chancellor JV, Bruce N. The burden of arthritis and nonsteroidal anti-inflammatory treatment. A European literature review. Pharmacoeconomics 2001;19:1-15.
7. Van Dieten HE. Systematic review of the cost effectiveness of prophylactic treatments in the prevention of gastropathy in patients with rheumatoid arthritis or osteoarthritis taking non-steroidal anti-inflammatory drugs. Annals of Rheumatic Diseases 2000;59:753-9.
8. March LM, Bachmeier CJ. Economics of osteoarthritis: a global perspective. Baillieres Clinical Rheumatology 1997;11:817-34.
9. th edtition,WB Saunders 1993.pp. 255-261.
10. Das SK, Ramakrishnan S. Osteoarthritis. In: Manual of Rheumatology (editors) Pispati PK, Borges NE, Nadkar MY, 2nd edition Indian Rheumatology Association, The National Book Depot, Mumbai, India, 2002.pp.240-259.
11. Felson DT. The epidemiology of knee osteoarthritis: results from the Framingham Osteoarthritis Study. Semin Arthritis Rheum 1990;20:42-50.
12. Parazzini F; Progretto Menopausa Italia Study Group. Menopausal status, hormone replacement therapy use and risk of self-reported physician-diagnosed osteoarthritis in women attending menopause clinics in Italy. Maturitas 2003 20;46:207-12.
13. Felson DT, Nevitt MC. The effects of estrogen on osteoarthritis. Curr Opin Rheumatol 1998;10:269-72.
14. Zhang Y, McAlindon TE, Hannan MT, et al. Estrogen replacement therapy and worsening of radiographic knee osteoarthritis: the Framingham Study. Arthritis Rheum 1998;41:1867-73.
15. Felson DT, Ahange Y, Anthony JM, et al. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. Annals of Internal Medicine 1992;116:535-9.
16. Lanyon P, Muir K, Doherty S, Doherty M. Assessment of a genetic contribution to osteoarthritis of the hip: sibling study. British Medical Journal 2000;321:1179-83.
17. Doherty M, Jones A, Cawston T. Osteoarthritis. In: Oxford Textbook of Rheumatology, 3rd Ed. (Eds: Isenberg, D.A. et al.), Oxford University Press, 2004; pp. 1091-1118.
18. Knowlton RG, Kalzenstein PL, Moskowitz RW, et al. Demonstration of genetic linkage of a polymorphism in the type II procollagen gene (Col2A1) to primary osteoarthritis associated with mild chondrodysplasia. New England Journal of Medicine 1990;322:526-30.
19. Uitterlinden AG, Burger H, van Dujin CM, et al. Adjacent genes, for COL2A1 and the vitamin D receptor, are associated with separate features of radiographic osteoarthritis of the knee. Arthritis and Rheumatism 2000;43:1456-64.
20. Lane NE, Nevitt MC. Osteoarthritis and bone mass. Journal of Rheumatology 1994;21:1393-6.
21. Felson DT. Epidemiology of hip and knee osteoarthritis. Epidemiologic Reviews 1988;10:1-28.
22. Wright V. Post-traumatic osteoarthritis - a medico-legal minefield. British Journal of Rheumatology 1990;29:474-8.
23. Gelber AC, Hochberg MC, Mead LA, et al. Joint injury in young adults and risk for subsequent knee and hip osteoarthritis. Annals of Internal Medicine 2000;133:321-8.
24. Ruddy S, Harris ED, Sledge CB, Kent NN. Kelly's Textbook of Rheumatology, 6th Ed., Philadelphia. WB Saunders, 2001;pp. 1410.
25. Kellgren JH, Moore R. Generalised osteoarthritis and Heberden's nodes. British Medical Journal 1952;1:181-7.
26. Acheson RM, Collart AB. New Haven Survey of joint diseases. XVII. Relationships between some systemic characteristics and osteoarthrosis in a general population. Annals of the Rheumatic Diseases 1975;34:379-87.
27. McAlindon TE, Snow S, Cooper C, Dieppe PA. Radiographic patterns of osteoarthritis of the knee joint in the community: the importance of the platellofemoral joint. Annals of the Rheumatic Diseases 1992;51:844-9.
28. Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991;34:505-14.
29. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
30. Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 1990;33:1601-10.
31. Spector TD, Hart DJ, Byrne J, et al. Definition of osteoarthritis of the knee for epidemiological studies. Annals of the Rheumatic Diseases 1993;52:790-4.
32. Croft P, Cooper C, Wickham C, Coggon D. Defining osteoarthritis of the hip for epidemiologic studies. American Journal of Epidemiology 1990;132:514-22.
33. Buckland-Wright JC, MacFarlane DG, Lynch JA, Clark B. Quantitative microfocal radiographic assessment of progression in osteoarthritis of the hand. Arthritis and Rheumatism 1990;33:57-65.
34. Pandelton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000;59:936-44.
35. Thomas KS, Muir KR, Doherty M. et al. Home based exercise programme for knee pain and knee osteoarthritis: randomised controlled trial. BMJ 2002;325:752-6.
36. Hinman RS, Bennell KL, Crossley KM, McConnell J. Immediate effects of adhesive tape on pain and disability in individuals with knee osteoarthritis. Rheumatology 2003;42:865-9.
37. Kirkley A, Webster-Bogaert S, Litchfield R. et al. The effect of bracing on varus gonarthrosis. J Bone Joint Surgery Am 1999;81:539-48.
38. Wegman A, vander Windt D, van Tulder M, Stalman W, deVries T. NSAID or acetaminophen for osteoarthritis of hip or knee. A systemic review of evidence and guidelines. J Rheumatol 2004;31:199-202.
39. Bell GM, Schnitzer TJ. Cox-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of pain in the elderly. Clin Geriatr Med 2001;17:489-502.
40. Matusumoto AK, Cavanaughr PF Jr. Etoricoxib. Newer Cox-2 inhibitor. Drugs Today (BARE);40:395-414.
41. Fenton C, Keating GM, Wagstaff AJ. Valdecoxib: A review of its use in management of osteoarthritis, rheumatoid arthritis, dysmenoulique and acute pain. Drugs 2004;64:1231-61.
42. Graham DJ, Campen D, Hui R, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclooxygenase 2 selective and non-selective, non-steroidal anti-inflammatory drugs: Nested case control study. Lancet 2005;365:475-81.
43. Lichtenstein DR, Syngal S, Wolfe MM. Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. The double-edged sword. Arthritis Rheum 1995;38:5-18.
44. Creamer P. Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheum 1999;11:417-21.
45. Baful N, Noveck R, Chipman H, et al. Efficacy and safety of extended release, once daily Tramadol in chronic pain. A randomized 12 weeks clinical trial in osteoarthritis of knee. J Pain Symptom Manage 2004;28:59-71.
46. EmKey R, Rosenthal N, Wu SC, Jordan D, Kamin M. Efficacy and safety of Tramadol / Acetaminophen tables (ultralet) as add on therapy for osteoarthritis pain subjects receiving Cox-2 nonsteroidal anti-inflammatory drug: a multicenter, randomized double blind, placebo controlled trial. J Rheumatol 2004;31:100-6.
47. Altman RD, Auen A, Holmburg CE, et al. Capsaicin cream 0.025% as monotherapy for osteoarthritis: a double-blind study. Sein Arthritis Rheum 1994;23:S25-S33.
48. Raynauld JP, Buckland-Wright C. Safety and efficacy of long-term intra-articular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2003;48:370-7.
49. Caborn D, Rush J, Lanzer W, Parenti D, Murray C. A randomised, single blind comparison of efficacy and tolerability of hylan GF-20 and triamcolone hexacelonide in patients with osteoarthritis of knee. J Rheumatol 2004;31:333-43.
50. Das SK, Chandra A, Sahani K, et al. A preliminary clinical trial to assess short term symptom modifying effect of a regimen containing colchicine in a selected subset of patients with osteoarthritis knee. J Ind Rheum Assoc 1999;7:8-11.
51. Lo GH, La Valley M, McAdlindon T, Felson D. In: Current thinking on viscosupplementation in osteoarthritis (Medscape Medical News, 2004; edited by Deborah Flapan). JAMA 2003;290:3113-21.
52. Raynauld JP, Torrance GW, Band PA. et al. A prospective randomized, pragmatic health outcomes trial evaluating the incorporation of hylan GF-20 into treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage 2002;10:506-17.
53. McColl G. Glucosamine for osteoarthritis of the knee. Aust Presc 2004;27:61-3.
54. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001;357:251-6.
55. Pavelka K, Gatterova J, Olejarova M, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 2002;162:2113-23.
56. Kelly GS. Role of glucosamine: sulfate and chondroitin sulfates in treatment of degenerative joint disease. Altern Med Rev 1998;3:227-39.
57. Bijisma JW. Glucosamine and chondroitin sulphate as a possible treatment for osteoarthritis. Ned Tijdschr Geneeskd 2002;146:1819-23.
58. Ricky F, Bruyere O, Ethgen O, et al. Structural and symptomatic efficacy of glucosamine and chondroitin sulphate in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med 2003;163:1514-22.
59. Bruyere O, Pavelka K, Rovati LC, et al. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3 year studies. Menopause 2004;11:134-5.
60. Chapman AB, Feller JA. Therapeutic arthroscopy for knee osteoarthritis: time to reconsider? Med J Aust 2003;179:179-80.